Slowing kidney disease with a new medicine
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new medicine (QRX-3) to see if it can slow down or prevent further kidney damage in people with chronic kidney disease. If you are at risk of your kidneys getting worse, this treatment might help keep your kidneys working longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease
- Your kidney function (eGFR) is less than 60
- Your kidney function is declining, but not too quickly (not dropping by more than 20% in the last year)
- You are willing to attend regular follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether carefully reducing or stopping some medicines (deprescribing) can help people with advanced kidney disease. The goal is to improve quality of life and avoid side effects from unnecessary medications.
This study compares two experimental treatments—one that reduces protein in urine and another that may help control blood sugar and weight—for people with chronic kidney disease. It aims to find safer, more effective ways to slow kidney damage.
This study tests a new drug called QRX3 for people in the hospital with a specific type of sudden kidney failure (acute tubular necrosis). The drug aims to help the kidneys recover, and the study will compare it to usual care.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This trial tests a drug (JMKX003142) for people with autosomal dominant polycystic kidney disease that is getting worse quickly. It may help slow down kidney damage.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.